Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LuCaFab (ITM-31)
i
Other names:
ITM-31, CAXII-targeting 177Lu radiolabeled antibody Fab fragment, Lu-177 labeled 6A10-Fab-fragments, ITM 31, ITM31
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
German Research Center for Environmental Health, ITM Isotopen Technologien Munchen
Drug class:
Beta radiation emitter, Carbonic anhydrase XII inhibitor
Related drugs:
‹
lutetium Lu 177 vipivotide tetraxetan (4)
lutetium Lu 177 dotatate (2)
177Lu-HER3 ARC (0)
AAA603 (0)
CAM-H2 (0)
yttrium-90 microspheres (0)
177Lu-edotreotide (0)
yttrium 90 microspheres (0)
177 Lu-FC705 (0)
lutetium Lu 177 vipivotide tetraxetan (4)
lutetium Lu 177 dotatate (2)
177Lu-HER3 ARC (0)
AAA603 (0)
CAM-H2 (0)
yttrium-90 microspheres (0)
177Lu-edotreotide (0)
yttrium 90 microspheres (0)
177 Lu-FC705 (0)
›
Associations
News
Trials
Filter by
Latest
over1year
RIT in GBM: Radioimmunotherapy With Lu-177 Labeled 6A10 Fab-fragments in Patients With Glioblastoma After Standard Treatment (clinicaltrials.gov)
P1, N=15, Recruiting, University Hospital Muenster | Initiation date: Oct 2022 --> Jun 2023
over 1 year ago
Trial initiation date
|
LuCaFab (ITM-31)
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login